Weaver Consulting Group »

Pfizer shares owned by Weaver Consulting Group

Quarter-by-quarter ownership of Pfizer (PFE) shares owned by Weaver Consulting Group from 13F filings

Historical chart of Weaver Consulting Group investment in Pfizer

Tip: Access up to 7 years of quarterly data

All positions including Pfizer held by Weaver Consulting Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pfizer by Weaver Consulting Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $361k 13k 27.75
2023-12-31 $289k 10k 28.79
2023-03-31 $211k 5.2k 40.80
2022-12-31 $286k 5.6k 51.24
2022-09-30 $243k 5.6k 43.72
2022-06-30 $296k 5.6k 52.50
2022-03-31 $298k 5.8k 51.80
2021-12-31 $363k 6.1k 59.03
2021-09-30 $267k 6.2k 43.07
2021-06-30 $241k 6.1k 39.23
2021-03-31 $231k 6.4k 36.30
2020-12-31 $213k 5.8k 36.78
2020-09-30 $202k 5.5k 36.66
2020-06-30 $180k 5.5k 32.67
2020-03-31 $170k 5.2k 32.64
2019-12-31 $244k 6.8k 35.95
2019-09-30 $177k 4.6k 38.75
2019-06-30 $163k 3.8k 43.26
2019-03-31 $162k 3.8k 42.99